ImmunityBio, Inc.
Ticker: 1326110
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 44.21+37.9% | 32.06+21.3% | 26.43+60.0% | 16.52+170.4% | 6.11+481.9% | 1.05+2525.0% | 0.04-50.0% | 0.08 |
| Total Income | 44.21+37.9% | 32.06+21.3% | 26.43+60.0% | 16.52+170.4% | 6.11+481.9% | 1.05+2525.0% | 0.04-50.0% | 0.08 |
| EXPENSES | ||||||||
| Expenditure | 114.00+30.0% | 87.69-10.3% | 97.71+20.7% | 80.95-6.3% | 86.36-14.0% | 100.38+5.4% | 95.24+18.7% | 80.22 |
| Tax | 0.01+125.0% | -0.04-114.8% | 0.27+217.4% | -0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -632.79-840.1% | -67.31+27.1% | -92.31+28.9% | -129.90-51.5% | -85.75+36.3% | -134.58-0.3% | -134.13-40.2% | -95.64 |
| Net Profit | -632.78-840.9% | -67.25+27.3% | -92.56+28.6% | -129.65-51.2% | -85.73+36.3% | -134.56-0.3% | -134.11-40.3% | -95.58 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.62-785.7% | -0.07+30.0% | -0.10+33.3% | -0.15-25.0% | -0.12+40.0% | -0.20+0.0% | -0.20-5.3% | -0.19 |
Corporate Events
Board MeetingIBRX
20269Jun
Board Meeting
2026 Annual Meeting of Stockholders for the election of nine…
SEC Filing ↗